Alto Neuroscience, Inc. (ANRO)
(Delayed Data from NYSE)
$10.85 USD
-0.15 (-1.36%)
Updated Oct 21, 2025 04:00 PM ET
After-Market: $10.85 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Alto Neuroscience, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ANRO 10.85 -0.15(-1.36%)
Will ANRO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ANRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANRO
All You Need to Know About Alto Neuroscience, Inc. (ANRO) Rating Upgrade to Buy
ANRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ANRO
Analysts’ Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), Glaukos (GKOS)
Expansion Breakout appears for ANRO after 80.92% move
Alto Neuroscience price target raised to $16 from $10 at Baird
Alto Neuroscience price target raised by $6 at Baird, here's why
Midday Fly By: AWS hit by outage, Kering sells beauty unit